Xstrahl to Feature SmART-RAD at RRS 2024 in Tucson, AZ
Xstrahl will demonstrate SmART-RAD and SmART-Contour at RRS 2024
Xstrahl, the leader in preclinical radiation research systems, will demonstrate SmART-RAD at the 70th Annual Meeting of the Radiation Research Society (RRS) at the Westin La Paloma Resort & Spa, in Tucson, AZ, Sept. 15-18.
SmART-RAD, a powerful 3D dose calculation software has been verified on Xstrahl’s range of cabinet irradiators and is suitable for any non-image guided irradiator. This advanced tool ensures researchers can deliver reproducible and accurate doses both in-vitro and in-vivo, addressing the increasing requirement for greater dose accuracy and standardized reporting as advised by agencies like the NIH.
“Xstrahl is excited to be showcasing SmART-RAD and SmART-Contour at RRS,” states Adrian Treverton, CEO of Xstrahl. “Through our partnership with SmART Scientific Solutions, we are able to bring tools to researchers that significantly extend the functionality and accuracy of both our SARRP and CIX systems.”
Xstrahl will also be highlighting our FLASH Suite, the first X-ray Based FLASH Irradiator Suite for translational radiation research. Xstrahl’s suite of photon FLASH irradiators give investigators the tools to expand preclinical radiation studies using a patented FLASH technique, further supporting translational research into effective cancer treatments.
Visit the Xstrahl booth to hear more about SARRP Beamline, the first image-guided platform for preclinical particle therapy research. Built on the robust and established SARRP platform, SARRP Beamline provides CT guidance and robotic alignment to perform accurate, targeted particle irradiations for small animal experiments. SARRP Beamline has been shown to be the ultimate adaptable platform for in vivo proton studies.
Visit Xstrahl at the 70th Annual Meeting of the Radiation Research Society (RRS) at the Westin La Paloma Resort & Spa, in Tucson, AZ, Sept. 15-18.
About Xstrahl
Xstrahl is a medical technology company that designs radiation delivery devices to support clinical teams and cancer researchers. For more than 25 years, Xstrahl has been shaping the development of superficial and orthovoltage radiation therapy and advancing preclinical radiation research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.
Learn more and contact us about Xstrahl at RRS 2024 here.
Click to see a brief demo on SmART-RAD, or click here to learn more about the research and to watch a webinar.
Click to see a brief demo on SmART-Countour.
To learn more about radiation research with Xstrahl, visit www.xstrahl.com/radiationresearch